PHLI PacificHealth Laboratories Inc (CE)

As Ryan Reed looks to make his next appearance in the No. 15 Venturini Motorsports racecar on the high-banked track of Talladega Superspeedway, he is proud to announce his new partner on board -- PacificHealth Laboratories, Inc (OTCQB: PHLI) (OTCBB: PHLI) and their premium sports product, ACCELERADE™.

Through PHLI, ACCELERADE has begun an exciting new joint venture with Ryan Reed, powering his health on the race track, and with Ryan's Mission.

As a JDRF National Celebrity Advocate, Ryan's awareness and funding drive for the cure of type 1 diabetes (T1D) inspired PHLI and ACCELERADE.

"We are very proud of our partnership with Ryan Reed and his mission to help inspire other athletes like himself with diabetes as well as to help fund research for a cure," said Fred Duffner, president and CEO of PacificHealth Laboratories. "We are proud to say that ACCELERADE is able to Power Ryan's Passion!"

"The partnership with ACCELERADE just seems perfect," said Ryan. "Ever since I was diagnosed with type 1 diabetes, my doctor (Dr. Anne Peters) told me to make sure I always have ACCELERADE in the race car to keep my blood sugar up during the race. I can't race without ACCELERADE."

Most racecar drivers usually have a water drink bag inside of their racecar to keep hydrated. Along with all the extra wires and gauges inside of Ryan's car to monitor his blood sugar levels, Ryan also has an extra drink bag with ACCELERADE in it to maintain his blood sugar.

"It is really neat that PacificHealth Labs found my story and need for their product so compelling that they joined my team and mission. It means a lot to have a company with so much passion stand behind me," said Ryan. "It is pretty cool that ACCELERADE is going to be in my drink bag and on the in car camera spot light at Talladega -- how perfect!"

Reed looks to back up his first Superspeedway ARCA start with Venturini Motorsports where he qualified on the front row.

"After running second most of the race at Daytona I know our chances are good here at Talladega. The guys at Venturini Motorsports have worked really hard to bring me a great racecar. I have a great team behind me and I just have to run a smart race," said Reed.

On-track activity, originally scheduled to begin on Thursday, May 3rd with practice at 10:00am has been rescheduled due to rain. Menards Pole Qualifying presented by Ansell, originally scheduled for 5:05pm CT, has been canceled. Drivers will line up according to the 2011 Owner Points. ARCA officials remain hopeful for the opportunity to practice later today.

The 94-lap, 250-mile International Motorsports Hall of Fame 250 will begin at 4:00pm CT. on Friday, May 4th. The ARCA race event will be aired live on SPEED TV. Live timing and scoring of all on-track activity will be presented by ARCA Nation at ARCARacing.com.

About PacificHealth Laboratories, Inc PacificHealth Laboratories, Inc. (OTCQB: PHLI) (OTCBB: PHLI), founded in 1996 by two prominent scientists, started with a singular purpose -- to help athletes achieve their personal goals. PacificHealth Laboratories never lost sight of that mission. Collaborating with some of the world's top nutritionists, biochemists and sports scientists, their research and products have reshaped sports nutrition. To learn more, visit www.pacifichealthlabs.com.

About Ryan Reed Ryan Reed is a NASCAR development driver racing under the Venturini Motorsports banner in the ARCA Racing Series presented by Menards.

Ryan was diagnosed with T1D in February 2011 and initially told by doctors his "racing career" was over. Armed with the passion and determination to fulfill his dreams, Reed shifted his focus and poured all his energy into managing his health and educating himself on the disease. He uses his racing platform and personal story to inspire others living with T1D to continue living life to its fullest through Ryan's Mission.

Reed's off-track goodwill has made him a National Celebrity Advocate of JDRF, the world's largest funder of research towards curing, treating and preventing T1D and its complications. Today, Reed is only one of three professional racecar drivers in the world to compete at the highest levels of racing with T1D.

Official: www.RyansMission.org | Twitter @driverRyanReed | Facebook: Ryan Reed

About Venturini Motorsports Venturini Motorsports (VMS), fielding cars in the ARCA Racing Series, is one of the premier NASCAR driver development programs in the country. The 2012 season marks the team's 30th Anniversary of competition in the ARCA Series. Multiple team championships and consistent on-track success, VMS has evolved into one of the most recognizable names in motorsports.

Since 2007, VMS has assisted in the career development of notable NASCAR drivers such as Joey Logano, Justin Allgaier, Steve Arpin, Brian Scott, Max Gresham, Miguel Paludo, Josh Richards, Ryan Blaney, and Scott Lagasse, Jr.

Official: www.VenturiniMotorsports.com | Twitter @VenturiniMotor | Facebook: Venturini Motorsports

Notice: This news release and oral statements made from time to time by Company representatives concerning the same subject matter may contain so-called "forward-looking statements." These statements can be identified by introductory words such as "expects," "plans," "will," "estimates,", "forecasts," "projects," or words of similar meaning and by the fact they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing new products and their potential. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known, such as general economic conditions, consumer product acceptance and competitive products, and others of which are not. No forward-looking statements are a guarantee of future results or events, and one should avoid placing undue reliance on such statements.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1971333 Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1971336

Contact: Stephen Kuchen 732-739-2900, x603 Email Contact